Quantrx Biomedical
QuantRx Biomedical Corporation engages in the development and commercialization of patented miniform pads (PADs) and PAD based over-the-counter products in the United States. It is also developing genomic diagnostics for the laboratory market based on its lateral flow patents, including RapidSense technology, a one-step lateral flow test. The company's PAD products are used for the treatment of h… Read more
Quantrx Biomedical (QTXB) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2022: 0.001x
Based on the latest financial reports, Quantrx Biomedical (QTXB) has a cash flow conversion efficiency ratio of 0.001x as of September 2022.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-3.76K) by net assets ($-2.84 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Quantrx Biomedical - Cash Flow Conversion Efficiency Trend (1994–2021)
This chart illustrates how Quantrx Biomedical's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Quantrx Biomedical Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Quantrx Biomedical ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
VALUE-HLDG INT
BE:NW4
|
N/A |
|
IBKS No. 22 Special Purpose Acquisition co.
KO:448760
|
N/A |
|
PRNR3F
SA:PRNR3F
|
N/A |
|
Secure Trust Bank PLC
LSE:STB
|
-0.575x |
|
LINGBAO GOLD -H- (LI9.SG)
STU:LI9
|
N/A |
|
CRPG3F
SA:CRPG3F
|
N/A |
|
Aquila SA
PA:ALAQU
|
0.052x |
|
BMIN3F
SA:BMIN3F
|
N/A |
Annual Cash Flow Conversion Efficiency for Quantrx Biomedical (1994–2021)
The table below shows the annual cash flow conversion efficiency of Quantrx Biomedical from 1994 to 2021.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2021-12-31 | $-2.64 Million | $-49.48K | 0.019x | -40.46% |
| 2020-12-31 | $-2.38 Million | $-74.92K | 0.031x | -65.06% |
| 2019-12-31 | $-2.13 Million | $-191.67K | 0.090x | -47.40% |
| 2018-12-31 | $-1.51 Million | $-257.92K | 0.171x | -14.79% |
| 2017-12-31 | $-749.55K | $-150.61K | 0.201x | +256.36% |
| 2016-12-31 | $-1.68 Million | $-94.64K | 0.056x | -64.33% |
| 2015-12-31 | $-1.43 Million | $-226.38K | 0.158x | -34.21% |
| 2014-12-31 | $-1.21 Million | $-291.91K | 0.240x | +10.85% |
| 2013-12-31 | $-689.87K | $-149.53K | 0.217x | -54.82% |
| 2012-12-31 | $-379.54K | $-182.10K | 0.480x | +115.17% |
| 2011-12-31 | $135.09K | $-427.38K | -3.164x | +21.28% |
| 2010-12-31 | $456.25K | $-1.83 Million | -4.019x | -107.88% |
| 2009-12-31 | $-21.88K | $-1.12 Million | 51.005x | +5601.78% |
| 2008-12-31 | $-3.13 Million | $-2.80 Million | 0.895x | +132.99% |
| 2007-12-31 | $1.84 Million | $-4.99 Million | -2.711x | -432.01% |
| 2006-12-31 | $3.57 Million | $-1.82 Million | -0.510x | +47.42% |
| 2005-12-31 | $1.05 Million | $-1.02 Million | -0.969x | -827.47% |
| 2004-12-31 | $-534.27K | $-71.19K | 0.133x | +1084.62% |
| 2003-12-31 | $-1.03 Million | $-11.58K | 0.011x | +1646.58% |
| 2002-12-31 | $-983.14K | $715.00 | -0.001x | -100.27% |
| 2001-12-31 | $-880.00K | $-240.00K | 0.273x | -96.68% |
| 2000-12-31 | $-190.00K | $-1.56 Million | 8.211x | +318.04% |
| 1999-12-31 | $640.00K | $-2.41 Million | -3.766x | +39.55% |
| 1998-12-31 | $740.00K | $-4.61 Million | -6.230x | -169.09% |
| 1997-12-31 | $730.00K | $-1.69 Million | -2.315x | +52.46% |
| 1996-12-31 | $770.00K | $-3.75 Million | -4.870x | -376.56% |
| 1995-12-31 | $3.19 Million | $-3.26 Million | -1.022x | -229.44% |
| 1994-12-31 | $2.45 Million | $-760.00K | -0.310x | -- |